ABCL vs MH
Comparison between AbCellera Biologics Inc (ABCL, Company) and McGraw Hill Inc (MH, Company).
ABCL is from the Healthcare sector, while MH is from the Consumer Defensive sector.
ABCL vs MH - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
ABCL
$1.74B
MH
$1.74B
Max Drawdown
ABCL
96.72%
Winner
MH
49.42%
Sharpe Ratio
Winner
ABCL
0.52
MH
-0.72
5Y Beta
ABCL
1.66
Winner
MH
0.23
Industry
ABCL
Biotechnology
MH
Education & Training Services
P/E Ratio
Winner
ABCL
-11.93
MH
49.15
Forward P/E
ABCL
27.55
Winner
MH
9.50
Debt to Equity
Winner
ABCL
0.00%
MH
354.42%
Free Cash Flow Yield
ABCL
-10.87%
Winner
MH
14.16%
P/S Ratio
ABCL
22.09
Winner
MH
0.83
P/B Ratio
Winner
ABCL
1.94
MH
2.46
ABCL vs MH - Historical Returns
Returns include dividend reinvestment.
1M
ABCL
+0.71%
Winner
MH
+0.84%
3M
Winner
ABCL
+40.00%
MH
-27.63%
6M
Winner
ABCL
+33.73%
MH
-36.77%
1Y
Winner
ABCL
+13.63%
MH
-43.76%
5Y(CAGR)
ABCL
-18.52%
MH
N/A
Max(CAGR)
Winner
ABCL
-34.10%
MH
-43.88%
ABCL vs MH - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | ABCL | MH |
|---|---|---|
| 2026 | +65.31% | -41.53% |
| 2025 | +12.87% | -2.94% |
| 2024 | -48.87% | N/A |
| 2023 | -39.83% | N/A |
| 2022 | -28.36% | N/A |
| 2021 | -63.43% | N/A |
| 2020 | -31.68% | N/A |
ABCL vs MH Drawdown Comparison
The maximum drawdown for ABCL was -96.72%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for MH was -49.42%, occurring on Jul 22, 2026. This drawdown has not yet recovered.
The current ABCL drawdown is -90.37%. The current MH drawdown is -46.86%.
| Rank | ABCL | MH |
|---|---|---|
| #1 | -96.72% Dec 11, 2020 - Apr 8, 2025 | -49.42% Nov 25, 2025 - Jul 22, 2026 |
| #2 | N/A | -36.06% Jul 24, 2025 - Nov 25, 2025 |
Correlation
Correlation between ABCL and MH is -0.78 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
-0.78
-101
Select Stocks to Compare
Popular: ABCL vs SPYMH vs SPY
More Comparisons
Compare with similar stocks